01373nas a2200337   4500000000100000008004100001260001300042653002000055653002500075653002800100653002200128653001100150653001900161653001100180653003000191653003700221653001400258653002600272653001600298653002900314100001300343700002000356700001400376700002000390700001500410245008200425300000900507490000700516520049800523022001401021       2007                            d  c2007 Feb10aAfrica, Western10aAntiprotozoal Agents10aDiagnosis, Differential10aFacial Dermatoses10aFemale10aHIV Infections10aHumans10aInjections, Intramuscular10aLeishmaniasis, Diffuse Cutaneous10aMeglumine10aMeglumine Antimoniate10aMiddle Aged10aOrganometallic Compounds1 aNiamba P1 aGoumbri-Lompo O1 aTraoré A1 aBarro-Traoré F1 aSoudré RT00aDiffuse cutaneous leishmaniasis in an HIV-positive patient in western Africa.  a32-40 v483 a<p>A 36-year-old HIV1-positive woman presented with a 6-month history of a progressive papular and nodular eruption of the face and subsequent extensive spread to the rest of the skin. The diagnosis of diffuse cutaneous leishmaniasis was established by direct examination and skin biopsy. This atypical form had a dramatic improvement after a 21-day treatment with meglumine antimoniate. This clinical form may be confused with other endemic diseases in western Africa, especially leprosy.</p>  a0004-8380